SCHULER AG

  • WKN: A0V9A2
  • ISIN: DE000A0V9A22
  • Land: Deutschland

Nachricht vom 04.04.2014 | 09:23

SCHULER AG: Delisting


SCHULER AG  / Key word(s): Delisting

04.04.2014 09:23

Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted
by DGAP - a company of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


Schuler AG: Delisting Göppingen, March 4, 2014 - The Board of Management of Schuler AG today resolved to apply for the delisting of Schuler AG shares. The Board of Management will submit an application to revoke its admission to trading on the Regulated Market to all stock exchanges on which shares of Schuler AG are traded on the Regulated Market (Frankfurt Stock Exchange and Stuttgart Stock Exchange). The Board of Management expects that the revocation will become effective six months after its publication by the respective stock exchange management. Shares of Schuler AG will then subsequently no longer be traded on the Regulated Market. Contact: Schuler AG, Thomas Herrlinger, Head of Investor Relations, POB 12 22, 73012 Göppingen, Tel.: + 49 (0)7161/66-204, Fax: 66-850, e-Mail: ir@schulergroup.com 04.04.2014 DGAP's Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de
Language: English Company: SCHULER AG Bahnhofstraße 41 73033 Göppingen Germany Phone: +49 (0)7161 66-204 Fax: +49 (0)716 166-850 E-mail: ir@schulergroup.com Internet: www.schulergroup.com ISIN: DE000A0V9A22 WKN: A0V9A2 Listed: Regulierter Markt in Frankfurt (General Standard), Stuttgart; Freiverkehr in Berlin, Düsseldorf, Hamburg, Hannover, München End of Announcement DGAP News-Service

Events im Fokus

Termine 2022

1./2. Juni 2022: Fachkonferenz Immobilien & Software | IT

13./14. Juli 2022: Fachkonferenz Beteiligungsgesellschaften & Consumer/Leisure

12./13. Oktober 2022: Fachkonferenz Finanzdienstleistungen/Technologie

News im Fokus

Deutsche Post AG: Bekanntgabe gemäß Art. 5 Abs. 1 der Verordnung (EU) Nr. 596/2014 i.V.m. Art. 2 Abs. 1 der Del. VO (EU) 2016/1052 der Kommission (in der jeweils gültigen Fassung)

28. Juni 2022, 11:00

Aktueller Webcast

Kinarus Therapeutics Holding AG

Replay KOL Webcast: Christian Pruente on wAMD and KIN001

27. Juni 2022

Aktuelle Research-Studie

STEICO SE

Original-Research: STEICO SE (von Montega AG): Kaufen

28. Juni 2022